B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioventus Inc
Accrued Liabilities Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Accrued Liabilities
$119.1m
CAGR 3-Years
6%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Accrued Liabilities
$49.3m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Accrued Liabilities
$265m
CAGR 3-Years
49%
CAGR 5-Years
17%
CAGR 10-Years
33%
Align Technology Inc
NASDAQ:ALGN
Accrued Liabilities
$574.6m
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Accrued Liabilities
$161.7m
CAGR 3-Years
52%
CAGR 5-Years
37%
CAGR 10-Years
17%
Merit Medical Systems Inc
NASDAQ:MMSI
Accrued Liabilities
$138.7m
CAGR 3-Years
-3%
CAGR 5-Years
9%
CAGR 10-Years
16%

See Also

What is Bioventus Inc's Accrued Liabilities?
Accrued Liabilities
119.1m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Accrued Liabilities amounts to 119.1m USD.

What is Bioventus Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
19%

Over the last year, the Accrued Liabilities growth was 5%. The average annual Accrued Liabilities growth rates for Bioventus Inc have been 6% over the past three years , 19% over the past five years .

Back to Top